Pfizer withdraws Bextra in South Africa.
D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004345:Drug Industry; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects*; D010146:Pain / Q000188:drug therapy; D013019:South Africa; D013449:Sulfonamides / Q000009:adverse effects*; D000096926:Benzenesulfonamides
D016861:Cyclooxygenase Inhibitors; D007555:Isoxazoles; D013449:Sulfonamides; C406224:valdecoxib; D000096926:Benzenesulfonamides